Science
Mechanism of Action
As an endopeptidase, CCH precisely cleaves native collagen within its triple helix region, demonstrating a broader substrate specificity than human collagenases. Specifically, CCH-aaes, a combination of AUX-I and AUX-II bacterial collagenases, targets and hydrolyzes Type I and Type III collagen with high specificity. In the context of cellulite, this enzymatic action facilitates 'enzymatic subcision' by degrading the collagen-rich fibrous septae that tether the skin to underlying fascia. This release resolves cellulite depressions, promoting a smoother skin surface. Additionally, it stimulates neocollagenesis (collagen remodeling) and reorganizes subcutaneous adipose tissue into smaller, more homogenous fat lobules. CCH effectively degrades both water-insoluble native and water-soluble denatured collagens through multiple cleavages.
Research
Clinical Evidence
High confidenceN/A
Key findings
- 01 Injectable CCH-aaes (0.84 mg per treatment area) significantly improved moderate-to-severe buttock cellulite in adult women. Pooled analysis of two phase-3 trials (RELEASE-1 and RELEASE-2) showed CCH-aaes-treated women were 5.9 times more likely than placebo-treated women to achieve a ≥2-level composite response at Day 71. Efficacy was consistent across Fitzpatrick skin types, with common adverse events including injection-site bruising and pain.
- 02 For Dupuytren's contracture, a minimal effective intralesional dose of 300 units was required to rupture cords, with effects increasing dose-dependently. Cellular studies revealed CCH inhibited fibroblast spreading, attachment, and proliferation in a dose- and time-dependent manner.
- 03 In laboratory settings for tissue dissociation, topical/in vitro concentrations of 0.1 mg/mL to 5 mg/mL are typical for digesting various tissues, with a general recommendation to initiate at 2.5 mg/mL. For cartilage dispersal, concentrations of 1-2 mg/mL are used.
Transparency
Dusting Analysis
R-Clostridium Histolyticum Collagenase H is a powerful enzyme predominantly used in prescription injectable treatments for medical conditions (e.g., cellulite, Dupuytren's contracture) or as a topical debriding agent for necrotic tissue. Its potent enzymatic activity means any concentration included in a cosmetic formulation would likely be intended for active effect rather than as a 'dusted' inactive amount. Given its medical classification and potential side effects, it is not an ingredient typically 'dusted' in conventional skincare products.
The Formula
Formulation
Stability
Solutions of crude collagenase (e.g., at 10 mg/mL) are stable when quickly frozen in aliquots and maintained at –20 °C; repeated freeze-thaw cycles are not advised. In aqueous solutions, measurable activity significantly declines within 3 hours at 4 °C. Lyophilized forms require gentle reconstitution with a diluent, avoiding shaking or vigorous agitation to prevent denaturation. Zinc ions (Zn2+) are essential for activity, though additional Zn2+ supplementation is typically not necessary unless a chelator is present. Krebs Ringer Buffer with calcium and BSA is a preferred buffering system. If excessive cell death is observed, reducing enzyme concentration and/or adding BSA or serum (0.5% and 5-10% respectively) is recommended for cell stabilization.
Conflicts
- Chelating agents (due to Zn2+ requirement)
- Certain metal ions (Na+, K+, Mg2+, Ca2+, Ni2+, Mn2+) have been shown to inhibit the activity of other bacterial collagenases, suggesting potential incompatibilities.
Safety
Safety Profile
Collagenase Clostridium Histolyticum (CCH) is FDA-approved for several medical conditions as a prescription injectable, including Dupuytren's contracture (since 2010), Peyronie's disease (since 2020), and moderate-to-severe buttock cellulite in adult women (CCH-aaes, brand name Qwo, approved July 6, 2020). Common side effects for injectable use include injection-site bruising, pain, hardening, itching, redness, discoloration, swelling, and warmth. More serious adverse events, though rare, can include hives, difficulty breathing, and anaphylaxis. For topical formulations used in debridement of necrotic tissue, reported side effects may include skin irritation, redness, burning at the application site, and an increased risk of bacterial infection. Its potent enzymatic activity requires cautious consideration for topical cosmetic use.
Your Skin
Skin Compatibility
Our Assessment
Verdict
While exceptionally effective as a prescription injectable for specific medical conditions like cellulite, its potent enzymatic nature, documented irritancy, and lack of established data for safe and effective topical cosmetic use make R-Clostridium Histolyticum Collagenase H questionable for general skincare formulations.
Related
Similar Ingredients
Finding similar ingredients…